RHEUMACEPT

Serial Number 90833367
733

Registration Progress

Application Filed
Jul 16, 2021
Under Examination
Jul 12, 2022
Approved for Publication
May 17, 2022
Published for Opposition
May 17, 2022
Registered

Basic Information

Serial Number
90833367
Filing Date
July 16, 2021
Published for Opposition
May 17, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Jul 11, 2024
Application
Pending
Classes
005

Rights Holder

Navidea Biopharmaceuticals, Inc.

03
Address
4100 Horizons Drive, Suite 205
Columbus, OH 43220

Ownership History

Navidea Biopharmaceuticals, Inc.

Original Applicant
03
Dublin, OH

Navidea Biopharmaceuticals, Inc.

Owner at Publication
03
Columbus, OH

Legal Representation

Attorney
Cynthia Moyer

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description
Jul 11, 2024 EXT4 S SOU EXTENSION 4 FILED
Jul 11, 2024 EX4G S SOU EXTENSION 4 GRANTED
Jul 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 1, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 1, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 1, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 1, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2024 EX3G S SOU EXTENSION 3 GRANTED
Jan 11, 2024 EXT3 S SOU EXTENSION 3 FILED
Jan 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2023 EX2G S SOU EXTENSION 2 GRANTED
Jul 10, 2023 EXT2 S SOU EXTENSION 2 FILED
Jul 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2023 EX1G S SOU EXTENSION 1 GRANTED
Jan 10, 2023 EXT1 S SOU EXTENSION 1 FILED
Jan 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 12, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 23, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 23, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 23, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 17, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 17, 2022 PUBO A PUBLISHED FOR OPPOSITION
Apr 27, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 11, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 6, 2022 DOCK D ASSIGNED TO EXAMINER
Sep 20, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Radiopharmaceutical imaging and detection agents for diagnosing and monitoring rheumatoid arthritis

Classification

International Classes
005